Teza Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,259
| Closed | -$3.87M | – | 705 |
|
|
2024
Q3 | $3.87M | Sell |
6,259
-7,551
| -55% | -$4.67M | 0.42% | 58 |
|
|
2024
Q2 | $7.64M | Buy |
13,810
+13,371
| +3,046% | +$7.39M | 0.94% | 12 |
|
|
2024
Q1 | $255K | Sell |
439
-2,704
| -86% | -$1.57M | 0.03% | 471 |
|
|
2023
Q4 | $1.67M | Buy |
+3,143
| New | +$1.67M | 0.28% | 107 |
|
|
2023
Q2 | – | Sell |
-1,524
| Closed | -$878K | – | 719 |
|
|
2023
Q1 | $878K | Buy |
1,524
+590
| +63% | +$340K | 0.19% | 165 |
|
|
2022
Q4 | $514K | Sell |
934
-3,699
| -80% | -$2.04M | 0.1% | 320 |
|
|
2022
Q3 | $2.35M | Buy |
4,633
+3,658
| +375% | +$1.86M | 0.49% | 42 |
|
|
2022
Q2 | $530K | Buy |
975
+571
| +141% | +$310K | 0.2% | 182 |
|
|
2022
Q1 | $239K | Sell |
404
-1,101
| -73% | -$651K | 0.09% | 336 |
|
|
2021
Q4 | $1M | Buy |
1,505
+6
| +0.4% | +$4K | 0.27% | 113 |
|
|
2021
Q3 | $856K | Sell |
1,499
-1,622
| -52% | -$926K | 0.41% | 67 |
|
|
2021
Q2 | $1.57M | Buy |
+3,121
| New | +$1.57M | 0.26% | 119 |
|
|
2020
Q4 | – | Sell |
-980
| Closed | -$433K | – | 431 |
|
|
2020
Q3 | $433K | Buy |
+980
| New | +$433K | 0.25% | 130 |
|
|
2019
Q3 | – | Sell |
-2,092
| Closed | -$614K | – | 613 |
|
|
2019
Q2 | $614K | Buy |
+2,092
| New | +$614K | 0.36% | 87 |
|
|
2018
Q1 | – | Sell |
-2,833
| Closed | -$538K | – | 492 |
|
|
2017
Q4 | $538K | Buy |
+2,833
| New | +$538K | 0.32% | 139 |
|
|
2017
Q2 | – | Sell |
-17,230
| Closed | -$2.65M | – | 343 |
|
|
2017
Q1 | $2.65M | Buy |
17,230
+15,160
| +732% | +$2.33M | 0.77% | 13 |
|
|
2016
Q4 | $292K | Buy |
+2,070
| New | +$292K | 0.41% | 84 |
|